HomeG28 • FRA
add
Tevogen Bio Holdings Inc
Previous close
€0.57
Day range
€0.51 - €0.54
Year range
€0.51 - €2.72
Market cap
125.83M USD
Avg Volume
4.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 5.44M | -36.68% |
Net income | -5.50M | 43.04% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -5.35M | 37.45% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 685.23K | -39.65% |
Total assets | 4.27M | 28.97% |
Total liabilities | 13.75M | 25.67% |
Total equity | -9.48M | — |
Shares outstanding | 196.71M | — |
Price to book | -6.36 | — |
Return on assets | -326.32% | — |
Return on capital | 563.96% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -5.50M | 43.04% |
Cash from operations | -3.19M | -6.95% |
Cash from investing | — | — |
Cash from financing | 1.90M | -32.14% |
Net change in cash | -1.29M | -606.65% |
Free cash flow | -964.16K | -417.15% |
About
Founded
2020
Headquarters
Website
Employees
18
